The scientific basis of combination therapy for chronic hepatitis B functional cure

医学 乙型肝炎表面抗原 乙型肝炎病毒 免疫学 免疫疗法 乙型肝炎 联合疗法 病毒载量 病毒 免疫系统 内科学
作者
Seng Gee Lim,Thomas F. Baumert,Carolina Boni,Ed Gane,Massimo Levrero,Anna S. Lok,Mala K. Maini,Norah A. Terrault,Fabien Zoulim
出处
期刊:Nature Reviews Gastroenterology & Hepatology [Springer Nature]
卷期号:20 (4): 238-253 被引量:69
标识
DOI:10.1038/s41575-022-00724-5
摘要

Functional cure of chronic hepatitis B (CHB) — or hepatitis B surface antigen (HBsAg) loss after 24 weeks off therapy — is now the goal of treatment, but is rarely achieved with current therapy. Understanding the hepatitis B virus (HBV) life cycle and immunological defects that lead to persistence can identify targets for novel therapy. Broadly, treatments fall into three categories: those that reduce viral replication, those that reduce antigen load and immunotherapies. Profound viral suppression alone does not achieve quantitative (q)HBsAg reduction or HBsAg loss. Combining nucleos(t)ide analogues and immunotherapy reduces qHBsAg levels and induces HBsAg loss in some patients, particularly those with low baseline qHBsAg levels. Even agents that are specifically designed to reduce viral antigen load might not be able to achieve sustained HBsAg loss when used alone. Thus, rationale exists for the use of combinations of all three therapy types. Monitoring during therapy is important not just to predict HBsAg loss but also to understand mechanisms of HBsAg loss using viral and immunological biomarkers, and in selected cases intrahepatic sampling. We consider various paths to functional cure of CHB and the need to individualize treatment of this heterogeneous infection until a therapeutic avenue for all patients with CHB is available. In this Review, the authors consider various paths to functional cure of chronic hepatitis B (CHB) and the need to individualize therapy of this heterogeneous infection until a therapeutic avenue for all patients with CHB is available.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lizi完成签到,获得积分10
刚刚
轻松的天真完成签到,获得积分10
刚刚
隋阳完成签到,获得积分10
1秒前
甜甜圈完成签到,获得积分10
1秒前
星空舒完成签到,获得积分10
1秒前
Raeno完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
思源应助Li采纳,获得10
2秒前
2秒前
zhovy完成签到,获得积分10
3秒前
搜集达人应助愉快的雪巧采纳,获得10
3秒前
daq完成签到,获得积分10
3秒前
打牙祭完成签到,获得积分10
3秒前
张惠完成签到,获得积分10
3秒前
3秒前
Ken921319005发布了新的文献求助50
4秒前
4秒前
柏凡发布了新的文献求助10
4秒前
4秒前
4秒前
bkagyin应助大宝慧采纳,获得10
4秒前
5秒前
小麦发布了新的文献求助10
5秒前
6秒前
正在加载发布了新的文献求助10
6秒前
niuguibin完成签到,获得积分10
6秒前
啾啾完成签到,获得积分10
6秒前
端庄白猫完成签到,获得积分10
7秒前
sks完成签到,获得积分10
7秒前
7秒前
卓飞扬完成签到,获得积分10
8秒前
yujie发布了新的文献求助10
8秒前
lixiao应助Small-violet采纳,获得10
8秒前
8秒前
qiqibaba发布了新的文献求助10
9秒前
深情安青应助江洋小偷采纳,获得10
9秒前
9秒前
9秒前
高分求助中
Evolution 10000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3147695
求助须知:如何正确求助?哪些是违规求助? 2798784
关于积分的说明 7831337
捐赠科研通 2455622
什么是DOI,文献DOI怎么找? 1306889
科研通“疑难数据库(出版商)”最低求助积分说明 627943
版权声明 601587